Hong Kong, China

Li Chen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Li Chen

Introduction

Li Chen is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of immunology, holding a total of 3 patents. His work focuses on methods and compositions that modulate the immune system, showcasing his dedication to advancing medical science.

Latest Patents

Li Chen's latest patents include innovative methods and compositions for modulating the immune system using arginase I. These patents disclose recombinant Arginase I proteins capable of depleting plasma arginine levels in a subject. The methods and compositions developed by Chen can effectively modulate immune system activity, which is crucial for treating immune disorders and preventing organ, tissue, or cell rejection after transplantation. Additionally, these methods can be utilized to address bone conditions in subjects.

Career Highlights

Li Chen is associated with Bio-Cancer Treatment International Limited, where he applies his expertise in immunology to develop groundbreaking treatments. His work has the potential to impact numerous patients suffering from immune-related conditions.

Collaborations

Li Chen collaborates with notable colleagues, including Gernot Schabbauer and Emine Sahin-Heco, who contribute to his research endeavors. Their combined efforts enhance the scope and effectiveness of the innovations being developed.

Conclusion

Li Chen's contributions to immunology through his patents and collaborations highlight his role as a key innovator in the field. His work not only advances scientific understanding but also holds promise for improving patient outcomes in various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…